Migraine and stroke: current perspectives

REFERENCES

• Bousser MG, Welch KMA. Relation between migraine and stroke. Lancet Neurol 2005; 4: 533–542
   PubMed Web of Science ®Google Scholar
• Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women. A prospective study. Neurology 2005; 64: 1020–1026
   PubMed Web of Science ®Google Scholar
• Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke. The Atherosclerosis Risk in Communities Study. Neurology 2005; 64: 1573–1577
   PubMed Web of Science ®Google Scholar
• Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995; 52: 129–134
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Fenton BT, Cheng SH, et al. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997; 54: 562–368
   PubMedGoogle Scholar
• Etmanan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005; 330: 63–67
   PubMedGoogle Scholar
• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004; 24 (Suppl. 1): S1—S160
   Google Scholar
• Agostoni E, Al iprandi A. The complications of migraine with aura. Neurol Sci 2006; 27 (Suppl. 2): S91—S95
   PubMedGoogle Scholar
• Welch KMA. Contemporary concepts of migraine pathogenesis. Neurology 2003; 61 (Suppl. 4): S2—S8
   PubMed Web of Science ®Google Scholar
• D'Andrea G, Nordera GP, Allais G. Treatment of aura: Solving the puzzle. Neurol Sci 2006; 27 (Suppl. 2): S96—S99
   PubMedGoogle Scholar
• Young WB, Gangal KS, Aponte RJ, et al. Migraine with unilateral motor symptoms (MUMS): A case control study. I Neurol Neurosurg Psychiatry 2007; 78: 553
   PubMed Web of Science ®Google Scholar
• Olesen J, Friberg L, Skyhoj-Olsen T, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990; 28: 791–798
   PubMed Web of Science ®Google Scholar
• Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol 1998; 43: 25–31
   PubMed Web of Science ®Google Scholar
• Hadjikhani N, Sanchez del Rio M, Wu O. et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Nat Acad Sci USA 2001; 98: 4687–4692.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Cortical spreading depression — better understanding and more questions. I Neurophysiol 2007; 97: 3827
   PubMed Web of Science ®Google Scholar
• Gupta V. Silent or non-clinical infarct-like lesions in the posterior circulation territory in migraine: Brain hypoperfusion or hyper-perfusion? Brain 2006; 129: E39
   PubMedGoogle Scholar
• Brennan KC, Beltran-Parrazal L, Lopez Valdes HE, et al. Distinct vascular conduction with cortical spreading depression. I Neurophysiol 2007; 97: 4143–4151
   PubMed Web of Science ®Google Scholar
• American Academy of Neurology. American Academy of Neurology Practice Guidelines, Saint Paul, MN: American Academy of Neurology, 2000
   Google Scholar
• Tsushima Y, Endo K. MR imaging in the evaluation of chronic or recurrent headache. Radiology 2005; 235: 575–579
   PubMed Web of Science ®Google Scholar
• Rovaris M, Bozzali M, Rocca MA, et al. An MR study of tissue damage in the cervical cord of patients with migraine. I Neurol Sci 2001; 183: 43–46
   PubMed Web of Science ®Google Scholar
• Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291: 427–434
   PubMed Web of Science ®Google Scholar
• Kruit MC, Launer Li, van Buchem MA, et al. MRI findings in migraine. Rev Neurol (Paris) 2005; 161: 661–665
   PubMed Web of Science ®Google Scholar
• Kruit MC, Launer 14, Ferrari MD, et al. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006; 37: 1109–1112
   PubMed Web of Science ®Google Scholar
• Gupta VK. White matter hyperintensities: pearls and pitfalls in interpretation of MRI abnormalities. Stroke 2004; 35: 2756–2757
   PubMed Web of Science ®Google Scholar
• Hamel E. Perivascular nerves and the regulation of cerebrovas-cular tone. I Appl Physiol 2006; 100: 1059–1064
   PubMed Web of Science ®Google Scholar
• Paemeleire K, Proot P, De Keyzer K, et al. Magnetic resonance angiography of the circle of Willis in migraine patients. Clin Neurol Neurosurg 2005; 107: 301–305
   PubMed Web of Science ®Google Scholar
• Fujita M, Fujiwara J, Make T, et al. The efficacy of sodium valproate and a MRA finding in confusional migraine. Brain Dev 2007; 29: 178–181
   PubMed Web of Science ®Google Scholar
• Marshall N, Maclaurin WA, Koulouris G. MRA captures vasospasm in fatal migrainous infarction. Headache 2007; 47: 280–302
   PubMed Web of Science ®Google Scholar
• Cutrer FM, Black DF. Imaging findings of migraine. Headache 2006; 46: 1597
   Web of Science ®Google Scholar
• Tietjen GE. Migraine as a systemic disorder. Neurology 2007; 68: 1555–1556
   PubMed Web of Science ®Google Scholar
• Schluter A, Kissig B. MR angiography in migrainous vasospasm. Neurology 2002; 59: 1 772
   Google Scholar
• Sanin LC, Mathew NT. Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction. Cephalalgia 1993; 13: 289–292
   PubMed Web of Science ®Google Scholar
• Gonzalez-Alegre P, Tippin J. Prolonged cortical electrical depression and diffuse vasospasm without ischemia in a case of severe hemiplegic migraine during pregnancy. Headache 2003; 43: 72–75
   PubMed Web of Science ®Google Scholar
• Boasso LE, Fisher AQ. Cerebral vasospasm in childhood migraine during the intermigrainous period. I Neuroimaging 2004; 14: 158–161
   PubMed Web of Science ®Google Scholar
• Calabrese LH, Dodick DW, Schwedt TJ, et al. Narrative review: Reversible cerebra vasoconstrictive syndromes. Ann Intern Med 2007; 146: 34–44
   PubMed Web of Science ®Google Scholar
• Vanmolkot FH, van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007; 68: 1563–1570
   PubMed Web of Science ®Google Scholar
• Yetkin E, Ozisik H, Ozcan C, et al. Decreased endothelium-dependent vasodilatation in patients with migraine: A new aspect to vascular pathophysiology of migraine. Coron Artery Dis 2006; 17: 29–33
   PubMed Web of Science ®Google Scholar
• Silva FA, Rueda-Clausen CF, Silva SY, et al. Endothelial function in patients with migraine during the interictal period. Headache 2007; 47: 45–51
   PubMed Web of Science ®Google Scholar
• Lee S-T, Chu K, Jung K-H, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008; 70: 1510-1517
   PubMed Web of Science ®Google Scholar
• Elkind MSV. Endothelial repair capacity and migraine. The fix is in. Neurology 2008; 70: 1506-1507
   PubMed Web of Science ®Google Scholar
• Weinberger J. Interactions between migraine and stroke. Curr Treat Options Neurol 2006; 8: 513–517
   PubMedGoogle Scholar
• Lee VH, Brown RD, Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection. A population-based study. Neurology 2006; 67: 1809–1812
   PubMed Web of Science ®Google Scholar
• Stovner Lj, Hagen K, Jensen R, Katsarava Z, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193–210
   PubMed Web of Science ®Google Scholar
• Tzourio C, Benslamia L, Guillon B, et al. Migraine and the risk of cervical artery dissection: A case-control study. Neurology 2002; 59: 435–437.
   PubMed Web of Science ®Google Scholar
• Pezzini A, Granella F, Grassi M, et al. History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia, 2005; 25: 575–580.
   PubMed Web of Science ®Google Scholar
• Olesen J, Jansen-Olesen I. Nitric oxide mechanisms in migraine. Pathol Biol (Paris) 2000; 48: 648–657
   PubMed Web of Science ®Google Scholar
• Shukla R, Barthwal MK, Srivastava N, et al. Blood nitrate levels in patients with migraine during headache-free period. Headache 2001; 41: 475–481
   PubMed Web of Science ®Google Scholar
• Terwindt GM, Haan J, Ophaff RA, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998; 121: 303–316
   PubMed Web of Science ®Google Scholar
• Hill DL, Daroff RB, Ducros A, et al. Most cases labeled as “retinal migraine” are not migraine. I Neuro-Ophthalmol 2007; 27: 3–8
   PubMed Web of Science ®Google Scholar
• Winterkorn JMS. “Retinal migraine” is an oxymoron. I Neuro-Ophthalmol 2007; 27: 1–2
   PubMed Web of Science ®Google Scholar
• Rose KM, Wong TY, Carson AP, et al. Migraine and retinal microvascular abnormalities. The Atherosclerosis Risk in Communities Study. Neurology 2007; 68: 1694–1700
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME. Migraine: Epidemiology, impact, and risk factors for progression. Headache 2005; 45 (Suppl. 1): S3—S13
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Silberstein SD. Hormone-related headache: Pathophysiology and treatment. CNS Drugs 2006; 20: 125–141
   PubMed Web of Science ®Google Scholar
• Bousser MG. Estrogens, migraine and stroke. Stroke 2004; 35 (Suppl. 1): S2652—S2656
   PubMedGoogle Scholar
• Patacchioli FR, Monnazzi P, Simeoni S, et al. Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine. I Headache Pain 2006; 7: 90–94
   PubMedGoogle Scholar
• Krause DN, Duckles SP, Pelligrino DA. Influence of sex steroid hormones on cerebrovascular function.] Appl Physiol 2006; 101: 1252–1261
   PubMed Web of Science ®Google Scholar
• Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 2004; 5: 129–133
   PubMed Web of Science ®Google Scholar
• Oterino A, Pascual J, Ruiz de Alegria C, et al. Association of migraine and ESR1 G325C polymorphism. Neuroreport 2006; 17: 61-64
   PubMed Web of Science ®Google Scholar
• Shearman AM, Cooper JA, Kotwinski PJ, et al. Estrogen receptor a gene variation and the risk of stroke. Stroke 2005; 36: 2281–2282
   PubMed Web of Science ®Google Scholar
• Tanis BC, Rosendaal FR. Venous and arterial thrombosis during oral contraceptive use: Risks and risk factors. Semin Vasc Med 2003; 3: 69–84
   PubMedGoogle Scholar
• Curtis KM, Mohllajee AP, Peterson HB. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: A systemic review. Contraception 2006; 73: 189–194
   PubMed Web of Science ®Google Scholar
• Allais G, De Lorenzo C, Mana O. et al. Oral contraceptives in women with migraine: Balancing risks and benefits. Neurol Sci 2004; 25 (Suppl. 3): S211—S214
   PubMedGoogle Scholar
• Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives. JAMA 2000; 284: 72–78
   PubMed Web of Science ®Google Scholar
• Evans RW, Becker WJ. Migraine and oral contraceptives. Headache 2006; 46: 328–331
   PubMed Web of Science ®Google Scholar
• James AH, Bushnell CD, Jamison MG, et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509–516
   PubMed Web of Science ®Google Scholar
• Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Eng I Med 1996; 335: 768–774
   PubMed Web of Science ®Google Scholar
• Bousser MG. Migraine, female hormones, and stroke. Cephalalgia 1999; 19: 75–79
   PubMed Web of Science ®Google Scholar
• MacGregor EA. Migraine and the menopause. I Br Menopause Soc 2006; 12: 104–108
   PubMedGoogle Scholar
• Finsterer J, Sommer O. Stiskal M, et al. Closure of a patent foramen ovale: Effective therapy of migraine and occipital stroke. Intl Neurosci 2005; 115: 119–127
   PubMed Web of Science ®Google Scholar
• Fisher DC, Fisher EA, Budd JH, et al. The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study. Chest 1995; 107: 1504-1509
   Google Scholar
• Wilmshurst P, Nightingale S, Pearson M, et al. Relation of atrial shunts to migraine in patients with ischemic stroke and peripheral emboli. Am] Cardiol 2006; 98: 831–833
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ, da Silveira Ribeiro L, Braga H, et al. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006; 26: 934–939
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R, et al. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart] 2006; 151: 922
   PubMedGoogle Scholar
• Tobias JM, Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache? Texas Heart Inst J 2006; 32: 362–365
   Web of Science ®Google Scholar
• Lechat P, Mas JL, Lascault G, et al. Prevalence of patient foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148–1152
   PubMed Web of Science ®Google Scholar
• Sastry S, Riding G, Morris J, et al. Young adult myocardial infarction and ischemic stroke. The role of paradoxical embolism and thrombophilia (The YAMIS Study)./ Am Coll Card 2006; 48: 686–691
   Google Scholar
• Lapergue B, Rosso C, Hadrane L, et al. Frequency of migraine attacks following stroke starts to decrease before PF0 closure. Neurology 2006; 67: 1099–1100
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R, et al. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int J Cardiol 2007; 120: 357–362
   PubMed Web of Science ®Google Scholar
• Anzola GP, Morandi E, Casilli F, et al. Different degrees of right-to-left shunting predict migraine and stroke: Data from 420 patients. Neurology 2006; 66: 765–767
   PubMed Web of Science ®Google Scholar
• Diener H-C, Weimar C. Patent foramen ovale, migraine and stroke: No reason to intervene. Nat Clin Pract 2006; 3: 176–177
   PubMedGoogle Scholar
• Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399–1401
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45: 493–495
   PubMed Web of Science ®Google Scholar
• Diener HC, Weimar C, Katsarava Z. Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol 2005; 18: 299–304
   PubMed Web of Science ®Google Scholar
• Anzola GP, Frisoni GB, Morandi E, et al. shunt-associated migraine responds favorably to atrial septal repair: A case-control study. Stroke 2006; 37: 430–434
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R, et al. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc Interv 2006; 67: 625–629
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: A new therapy for migraine. Catheter Cardiovasc Interv 2007; 69: 277–284
   PubMed Web of Science ®Google Scholar
• Bousser MG. [Patent foramen ovale and migraine]. Rev Neurol (Paris) 2007; 163: 17–25
   PubMed Web of Science ®Google Scholar
• Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003; 139: 753–760
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Salehian O. Hazards of percutaneous PF0 closure. Eur J Echocard 2005; 6: 393–395
   PubMedGoogle Scholar
• Bijl JM, Ruygrok PN, Hornung TS, et al. Percutaneous closure of patient foramen ovale. Intern Med] 2005; 35: 706–710
   Web of Science ®Google Scholar
• Cannas A, Solla P, Mascia MM, et al. Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts. Cephalalgia 2006; 26: 1238–1241
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Al-Qasmi MM, Gunda P, et al. Sneddon's syndrome: Another migraine-stroke association? Cephalalgia 2006; 26: 225–232
   PubMed Web of Science ®Google Scholar
• Shen AL, Ryu Si, Lin SK. Concurrent moyamoya disease and Graves' thyrotoxicosis: Case report and literature review. Acta Neurol Taiwan 2006; 15: 114–119
   PubMedGoogle Scholar
• Black DF, Bartleson JD, Bell ML, Lachance DH. SMART: Stroke-like migraine attacks after radiation therapy. Cephalalgia 2006; 26: 1137–1142
   PubMed Web of Science ®Google Scholar
• Razvi SSM, Bone I. Single gene disorders causing ischaemic stroke. J Neurol 2006; 253: 685–700
   PubMed Web of Science ®Google Scholar
• Guidetti D, Casali B, Mazzei RL, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoence-phalopathy. Clin Exp Hypertens 2006; 28: 271–277
   PubMed Web of Science ®Google Scholar
• Jen J, Cohen AH, Yue Q, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997; 49: 1322–1330
   PubMed Web of Science ®Google Scholar
• Seifried C, Sitzer M, Jen J, et al. HERNS. A rare, hereditary, multisystemic disease with cerebral microangiopathy. Nervenarzt 2005; 76: 1191–1195
   PubMed Web of Science ®Google Scholar
• Palermo TM, Platt-Houston C, Kiska RE, et al. Headache symptoms in pediatric sickle cell patients. I Pediatr Hematol Oncol 2005; 27: 420–424
   PubMed Web of Science ®Google Scholar
• Silva GS, Vicari P, Figueiredo MS, et al. Migraine-mimicking headache and sickle cell disease: A transcranial Doppler study. Cephalalgia 2006; 26: 678–683
   PubMed Web of Science ®Google Scholar
• Scher At, Terwindt GM, Verschuren WMM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006; 59: 372–375
   PubMed Web of Science ®Google Scholar
• Bottini F, Celle ME, Calevo MG, et al. Metabolic and genetic risk factors for migraine in children. Cephalalgia 2006; 26: 731–737
   PubMed Web of Science ®Google Scholar
• Tournier-Lasserve E, lba-Zizen MT, Romero N, et al. Autosomal dominant syndrome with stroke-like episodes and leukoence-phalopathy. Stroke 1991; 22: 1297–1302
   PubMed Web of Science ®Google Scholar
• Gladstone JP, Dodick DW. Migraine and cerebral white matter lesions: when to suspect. Cerebral autosomal dominant arterio-pathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 2005; 11: 19–29
   PubMed Web of Science ®Google Scholar
• Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. Neurol Sci 2005; 26: 117–124
   PubMed Web of Science ®Google Scholar
• Finsterer J. Central nervous system manifestations of mitochon-drial disorders. Acta Neurol Scand 2006; 114: 217–238
   PubMed Web of Science ®Google Scholar
• Majamaa-Voltti KAM, Winqvist S, Remes AM, et al. A 3-year clinical follow-up of adult patients with 3243A>G in mitochon-drial DNA. Neurology 2006; 66: 1470–1475
   PubMed Web of Science ®Google Scholar
• Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurbiol 2006; 32: 359–373
   PubMed Web of Science ®Google Scholar
• Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population. Am I hum Genet 1998; 63: 447–454
   PubMed Web of Science ®Google Scholar
• Buzzi MG, Di Gennaro G, D'Onofrio M, et al. mtDNA A3243G MELAS mutation is not associated with multigenerational female migraine. Neurology 2000; 54: 1005–1007
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004; 24 (Suppl. 2): 52—S7
   PubMedGoogle Scholar
• Young WB, Mannix L, Adelman JU, et al. Cardiac risk factors and the use of triptans: a survey study. Headache 2000; 40: 587–591
   PubMed Web of Science ®Google Scholar
• Evans RW, Lipton RB. Topics in migraine management: A survey of headache specialists highlights some controversies. Neurol Clin 2001; 19: 1–21
   PubMed Web of Science ®Google Scholar
• Hall GC, Brown MM, Mo J, et al. Triptans in migraine. The risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62: 563–568
   PubMed Web of Science ®Google Scholar
• Maclntyre PD, Bhargava B, Hogg KJ, et al. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmon-ary, and coronary circulation. Circulation 1993; 87: 401–405
   PubMed Web of Science ®Google Scholar
• Dixon RM, Meire HB, Evans DH, et al. E. Cephalalgia 1997; 17: 639–646
   PubMed Web of Science ®Google Scholar
• de Hoon JN, Poppe KA, Thijssen HH, et al. Dihydroergotamine: Discrepancy between arterial, arteriolar and pharmacokinetic data. Br] Clin Pharmacol 2001; 52: 45–51
   PubMed Web of Science ®Google Scholar
• Newman CM, Starkey I, Buller N, et al. Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries. Eur I Clin Pharmacol 2005; 61: 733–742
   PubMed Web of Science ®Google Scholar
• Edvinsson I, Uddman E, Wackenfors A, et al. Triptan-induced contractile (5HT1B receptor) responses in human cerebral and coronary arteries: Relationship to clinical effect. Clin Sci (Lond) 2005; 109: 335–342
   PubMed Web of Science ®Google Scholar
• Evers S, Heuel T, Frese A, et al. The impact of different antimigraine compounds on platelet and erythrocyte aggregation. Cephalalgia 2006; 26: 920–924
   PubMed Web of Science ®Google Scholar
• Robbins L. Frequent triptan use: Observations on safety issues. Headache 2004; 44: 178–182
   PubMed Web of Science ®Google Scholar
• Dash S, Bogdanova O. Xavier A, et al. Cerebral vasospasm from sumatriptan. Neurology 2004; 63: 2128
   PubMed Web of Science ®Google Scholar
• Jayamaha JE, Street MK. Fatal cerebellar infarction in a migraine sufferer whilst receiving sumatriptan. Intensive Care Med 1995; 21: 82–83
   PubMed Web of Science ®Google Scholar
• Nanri K, Niiyama K, Utsumi H, et al. A case of migrainous infarction accompanying idiopathic thrombocytopenic purpura. Rinsho Shinkeigaku 2002; 42: 868–872
   PubMedGoogle Scholar
• Curro G, Baccarani U, Adani GL, et al. Transient ischemic attack after rizatriptan administration in a liver transplant recipient: A case report. Transplant Proc 2006; 38: 3138–3139
   PubMed Web of Science ®Google Scholar
• Arora A, Arora S. Spontaneous splenic infarction associated with sumatriptan use./ Headache Pain 2006; 7: 214–216.
   PubMedGoogle Scholar
• Fulton JA, Kahn J, Nelson LS, Hoffman RS. Renal infarction during the use of rizatriptan and zolmitriptan: Two case reports. Clin Toxicol (Phila) 2006; 44: 177–180
   PubMed Web of Science ®Google Scholar
• Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: History, pharmacology, and efficacy. Headache 2003; 43: 144–166
   PubMed Web of Science ®Google Scholar
• Lindboe CF, Dahl T, Rostad B. Fatal stroke in migraine: A case report with autopsy findings. Cephalalgia 1989; 9: 277–280
   PubMed Web of Science ®Google Scholar
• Paez de la Torre E, Lasic-Toccalino G, Mercado—Diez F, et al. Multifocal brain haemorrhage associated with migraine and medication abuse. Rev Neurol 2003; 37: 840–842
   PubMed Web of Science ®Google Scholar
• Wammes-van der Heijden EA, Rah imtoola H, Leufkens HG, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006; 67: 1128–1134
   PubMed Web of Science ®Google Scholar